TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study to Estimate the Impact of a Screening and Referral Service on Contraceptive Use
Brief Summary: The specific aim of this pilot study is to estimate the impact of a new digital health service on the uptake of family planning among Kenyan women with an unmet need for contraception. Enrolled women will be randomized to a control arm or an encouragement arm that will receive a special invitation to try the new service.


Options:
A: Arm Label: Encouragement Arm; Type: EXPERIMENTAL; Interventions: Other: digital family planning screening and referral service | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: digital family planning screening and referral service; Assigned to Arm(s): Encouragement Arm
B: Arm Label: Clinic group 1; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth messaging | Arm Label: Clinic group 2; Type: EXPERIMENTAL; Interventions: Behavioral: Transport Payments | Arm Label: Clinic group 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: mHealth messaging; Assigned to Arm(s): Clinic group 1 | Intervention Type: BEHAVIORAL; Name: Transport Payments; Assigned to Arm(s): Clinic group 2
C: Arm Label: cMM and Text Messaging; Type: OTHER; Interventions: Behavioral: cMM, Behavioral: Text Messaging | Arm Label: cMM Only; Type: OTHER; Interventions: Behavioral: cMM | Arm Label: Text Messaging Only; Type: OTHER; Interventions: Behavioral: Text Messaging | Arm Label: Neither cMM nor Text Messaging; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: cMM; Assigned to Arm(s): cMM Only, cMM and Text Messaging | Intervention Type: BEHAVIORAL; Name: Text Messaging; Assigned to Arm(s): Text Messaging Only, cMM and Text Messaging
D: Intervention Type: BEHAVIORAL; Name: Pulse; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study to Estimate the Impact of a Screening and Referral Service on Contraceptive Use
Brief Summary: The specific aim of this pilot study is to estimate the impact of a new digital health service on the uptake of family planning among Kenyan women with an unmet need for contraception. Enrolled women will be randomized to a control arm or an encouragement arm that will receive a special invitation to try the new service.


Options:
A: Arm Label: Short Message Service (SMS) group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS message | Arm Label: Usual care; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Intervention Type: BEHAVIORAL; Name: SMS message; Assigned to Arm(s): Short Message Service (SMS) group | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care
B: Arm Label: Encouragement Arm; Type: EXPERIMENTAL; Interventions: Other: digital family planning screening and referral service | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: digital family planning screening and referral service; Assigned to Arm(s): Encouragement Arm
C: Arm Label: Personalized Reminder Texting (iTAB) + Psychoeducation; Type: EXPERIMENTAL; Interventions: Behavioral: individualized Texting for Adherence Building (iTAB) | Arm Label: Psychoeducation (CTRL); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychoeducation | Intervention Type: BEHAVIORAL; Name: individualized Texting for Adherence Building (iTAB); Assigned to Arm(s): Personalized Reminder Texting (iTAB) + Psychoeducation | Intervention Type: BEHAVIORAL; Name: Psychoeducation; Assigned to Arm(s): Psychoeducation (CTRL)
D: Arm Label: health education; Type: EXPERIMENTAL; Interventions: Other: health education | Arm Label: no health education; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: health education; Assigned to Arm(s): health education

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study to Estimate the Impact of a Screening and Referral Service on Contraceptive Use
Brief Summary: The specific aim of this pilot study is to estimate the impact of a new digital health service on the uptake of family planning among Kenyan women with an unmet need for contraception. Enrolled women will be randomized to a control arm or an encouragement arm that will receive a special invitation to try the new service.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text message; Type: ACTIVE_COMPARATOR; Interventions: Other: SMS reminder message | Arm Label: Text message and voice call; Type: ACTIVE_COMPARATOR; Interventions: Other: Voice call + SMS message | Intervention Type: OTHER; Name: SMS reminder message; Assigned to Arm(s): Text message | Intervention Type: OTHER; Name: Voice call + SMS message; Assigned to Arm(s): Text message and voice call
B: Intervention Type: BEHAVIORAL; Name: Pulse; Assigned to Arm(s): N/A
C: Arm Label: General health information; Type: PLACEBO_COMPARATOR; Interventions: Other: general health information | Arm Label: Influenza and general health information; Type: ACTIVE_COMPARATOR; Interventions: Other: influenza and general health information | Intervention Type: OTHER; Name: influenza and general health information; Assigned to Arm(s): Influenza and general health information | Intervention Type: OTHER; Name: general health information; Assigned to Arm(s): General health information
D: Arm Label: Encouragement Arm; Type: EXPERIMENTAL; Interventions: Other: digital family planning screening and referral service | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: digital family planning screening and referral service; Assigned to Arm(s): Encouragement Arm

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fluoroscopic Guided Radiofrequency of Genicular Nerves for Pain Alleviation in Chronic Knee Osteoarthritis : A Single-blind Randomized Controlled Trial.
Brief Summary: Osteoarthritis (OA) affects aged above 45 years. RF has been used for several painful conditions. There have been a few attempts to use RF current for the treatment of painful conditions of joints of the extremities. It was also used for the treatment of painful conditions of the hip joint.


Options:
A: Arm Label: Cooled radiofrequency; Type: EXPERIMENTAL; Interventions: Device: Cooled Radiofrequency | Arm Label: Corticosteroid injection; Type: ACTIVE_COMPARATOR; Interventions: Drug: Corticosteroid injection | Intervention Type: DEVICE; Name: Cooled Radiofrequency; Assigned to Arm(s): Cooled radiofrequency | Intervention Type: DRUG; Name: Corticosteroid injection; Assigned to Arm(s): Corticosteroid injection
B: Arm Label: All Enrolled Participants; Type: N/A; Interventions: Drug: Standard of care for treatment of osteoarthritis (OA) of knee(s) | Intervention Type: DRUG; Name: Standard of care for treatment of osteoarthritis (OA) of knee(s); Assigned to Arm(s): All Enrolled Participants
C: Arm Label: Conventional Radiofrequency of the genicular nerves; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional Radiofrequency ablation of the genicular nerves | Arm Label: Cooled Radiofrequency of the genicular nerves; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cooled Radiofrequency ablation of the genicular nerves | Arm Label: Sham procedure; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham procedure | Intervention Type: PROCEDURE; Name: Conventional Radiofrequency ablation of the genicular nerves; Assigned to Arm(s): Conventional Radiofrequency of the genicular nerves | Intervention Type: PROCEDURE; Name: Cooled Radiofrequency ablation of the genicular nerves; Assigned to Arm(s): Cooled Radiofrequency of the genicular nerves | Intervention Type: PROCEDURE; Name: Sham procedure; Assigned to Arm(s): Sham procedure
D: Arm Label: radiofrequency group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radiofrequency | Arm Label: conventional group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paracetamol (conventional), Drug: Ketorolac Tromethamine (conventional) | Intervention Type: PROCEDURE; Name: radiofrequency; Assigned to Arm(s): radiofrequency group | Intervention Type: DRUG; Name: Paracetamol (conventional); Assigned to Arm(s): conventional group | Intervention Type: DRUG; Name: Ketorolac Tromethamine (conventional); Assigned to Arm(s): conventional group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Trial on Efficacy and Safety of a Formula Salt With Very Low Sodium (Manlikang) in Reducing Salt Intake and Blood Pressure Among Patients With Hypertension in Community
Brief Summary: This study is a single arm trial with before-after comparison design. Three groups of patients with hypertension will be recruited: not taking antihypertension drugs and having normal renal function, taking antihypertension drugs and having normal renal function, and having abnormal renal function without regards of antihypertension drugs use. Each group includes 30 patients. Based on renal function test, the investigators provide the Manlikang containing potassium chloride to patients with normal renal function, and provide the Manlikang not containing potassium chloride to patients with abnormal renal function. All hypertension patients will use the formula salt with very low sodium (Manlikang) for six weeks, and will be followed up at 1, 2, 4 and 6 weeks. The primary outcome will be the decrease of patients' systolic blood pressure at the end of the trial.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Reduced-sodium added-potassium salt substitute; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary sodium reduction | Intervention Type: BEHAVIORAL; Name: Dietary sodium reduction; Assigned to Arm(s): Reduced-sodium added-potassium salt substitute
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Dietary sodium reduction; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary sodium reduction | Intervention Type: BEHAVIORAL; Name: Dietary sodium reduction; Assigned to Arm(s): Dietary sodium reduction
C: Arm Label: Blood pressure-measurement; Type: EXPERIMENTAL; Interventions: Device: cuff device (Omron HBP-1300-E Pro), Device: iPhone 4s | Intervention Type: DEVICE; Name: cuff device (Omron HBP-1300-E Pro); Assigned to Arm(s): Blood pressure-measurement | Intervention Type: DEVICE; Name: iPhone 4s; Assigned to Arm(s): Blood pressure-measurement
D: Arm Label: hypertension patients; Type: EXPERIMENTAL; Interventions: Dietary Supplement: formula salt with very low sodium (Brand name: Manlikang) | Intervention Type: DIETARY_SUPPLEMENT; Name: formula salt with very low sodium (Brand name: Manlikang); Assigned to Arm(s): hypertension patients

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Canadian Study on the Association of Pessary With Progesterone
Brief Summary: Prematurity is the leading cause of neonatal morbidity causing more than 1 million deaths worldwide per year. In 2012, a randomized controlled trial (RCT) testing "pessary" (silicone ring placed around the cervix) versus "no pessary" in patients with a short cervix showed a 4-fold reduction in the rate of spontaneous prematurity \<34 weeks of gestation and a reduction in perinatal morbidity and mortality. This result was not found in a subsequent RCT and another study on the subject had to be stopped in the face of slow recruitment. Currently, the obstetric scientific community believes that other RCTs are needed before using the pessary in the clinic as a therapeutic option to prevent prematurity in the presence of a short cervix. However, before starting a large RCT, it is important to test the feasibility of recruitment.


Options:
A: Arm Label: Expectant Management; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Placement of cervical pessary since 23 weeks until 37 weeks; Type: EXPERIMENTAL; Interventions: Device: Device: Silicon ring (Arabin Pessary) | Intervention Type: DEVICE; Name: Device: Silicon ring (Arabin Pessary); Assigned to Arm(s): Placement of cervical pessary since 23 weeks until 37 weeks
B: Arm Label: Intravaginal progesterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Prometrium | Arm Label: Intravaginal progesterone and pessary; Type: EXPERIMENTAL; Interventions: Drug: Prometrium, Device: Dr. Arabin, cerclage pessary perforated | Intervention Type: DRUG; Name: Prometrium; Assigned to Arm(s): Intravaginal progesterone, Intravaginal progesterone and pessary | Intervention Type: DEVICE; Name: Dr. Arabin, cerclage pessary perforated; Assigned to Arm(s): Intravaginal progesterone and pessary
C: Arm Label: pessary; Type: EXPERIMENTAL; Interventions: Device: pessary | Arm Label: Progesterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Progesterone | Intervention Type: DEVICE; Name: pessary; Assigned to Arm(s): pessary
D: Arm Label: Progesterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone | Arm Label: Progesterone plus Experimental device; Type: EXPERIMENTAL; Interventions: Device: Pessary | Intervention Type: DEVICE; Name: Pessary; Assigned to Arm(s): Progesterone plus Experimental device | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Progesterone

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Post-Market, Multicenter, Prospective, Randomized Clinical Trial Comparing 10 kHz Spinal Cord Stimulation (HF10™ Therapy) Combined With Conventional Medical Management to Conventional Medical Management Alone in the Treatment of Chronic, Intractable, Neuropathic Limb Pain
Brief Summary: This post-market study is being conducted to document comparative safety, clinical effectiveness, and cost-effectiveness of the addition of HF10™ therapy to CMM compared with CMM alone in subjects with chronic, intractable, neuropathic lower limb pain due to diabetic neuropathy (Painful Diabetic Neuropathy or PDN). This study is a multi-center, prospective, randomized comparison of the two treatments.


Options:
A: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Device: PINS Spinal Cord Stimulator | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Device: PINS Spinal Cord Stimulator | Intervention Type: DEVICE; Name: PINS Spinal Cord Stimulator; Assigned to Arm(s): Control, Experimental
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: Pregabalin 300 mg/day; Type: EXPERIMENTAL; Interventions: Drug: pregabalin | Arm Label: Pregabalin 600 mg/day; Type: EXPERIMENTAL; Interventions: Drug: pregabalin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): Pregabalin 300 mg/day | Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): Pregabalin 600 mg/day
C: Arm Label: HF10 therapy plus CMM; Type: ACTIVE_COMPARATOR; Interventions: Device: Senza HF10 Therapy | Arm Label: CMM Alone; Type: OTHER; Interventions: Other: CMM | Intervention Type: DEVICE; Name: Senza HF10 Therapy; Assigned to Arm(s): HF10 therapy plus CMM | Intervention Type: OTHER; Name: CMM; Assigned to Arm(s): CMM Alone
D: Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Post-Market, Multicenter, Prospective, Randomized Clinical Trial Comparing 10 kHz Spinal Cord Stimulation (HF10™ Therapy) Combined With Conventional Medical Management to Conventional Medical Management Alone in the Treatment of Chronic, Intractable, Neuropathic Limb Pain
Brief Summary: This post-market study is being conducted to document comparative safety, clinical effectiveness, and cost-effectiveness of the addition of HF10™ therapy to CMM compared with CMM alone in subjects with chronic, intractable, neuropathic lower limb pain due to diabetic neuropathy (Painful Diabetic Neuropathy or PDN). This study is a multi-center, prospective, randomized comparison of the two treatments.


Options:
A: Arm Label: SCS + OMM; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal Cord Stimulation (SCS), Drug: Optimal Medical Management (OMM) | Arm Label: OMM alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Optimal Medical Management (OMM) | Intervention Type: DEVICE; Name: Spinal Cord Stimulation (SCS); Assigned to Arm(s): SCS + OMM | Intervention Type: DRUG; Name: Optimal Medical Management (OMM); Assigned to Arm(s): OMM alone, SCS + OMM
B: Arm Label: Early off-stimulation (group B); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Arm Label: Early on-stimulation (group A); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Intervention Type: DEVICE; Name: Spinal Cord Stimultion (SCS); Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A) | Intervention Type: DEVICE; Name: Spinal cord nerve stimulation; Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A)
C: Arm Label: HF10 therapy plus CMM; Type: ACTIVE_COMPARATOR; Interventions: Device: Senza HF10 Therapy | Arm Label: CMM Alone; Type: OTHER; Interventions: Other: CMM | Intervention Type: DEVICE; Name: Senza HF10 Therapy; Assigned to Arm(s): HF10 therapy plus CMM | Intervention Type: OTHER; Name: CMM; Assigned to Arm(s): CMM Alone
D: Arm Label: Spinal Cord Stimulation; Type: EXPERIMENTAL; Interventions: Procedure: Spinal Cord Stimulation | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Spinal Cord Stimulation; Assigned to Arm(s): Spinal Cord Stimulation

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Post-Market, Multicenter, Prospective, Randomized Clinical Trial Comparing 10 kHz Spinal Cord Stimulation (HF10™ Therapy) Combined With Conventional Medical Management to Conventional Medical Management Alone in the Treatment of Chronic, Intractable, Neuropathic Limb Pain
Brief Summary: This post-market study is being conducted to document comparative safety, clinical effectiveness, and cost-effectiveness of the addition of HF10™ therapy to CMM compared with CMM alone in subjects with chronic, intractable, neuropathic lower limb pain due to diabetic neuropathy (Painful Diabetic Neuropathy or PDN). This study is a multi-center, prospective, randomized comparison of the two treatments.


Options:
A: Arm Label: Spinal Cord Stimulation; Type: EXPERIMENTAL; Interventions: Device: WaveWriter | Arm Label: Conventional Medical Management; Type: OTHER; Interventions: Other: Conventional Medical Managament | Intervention Type: DEVICE; Name: WaveWriter; Assigned to Arm(s): Spinal Cord Stimulation | Intervention Type: OTHER; Name: Conventional Medical Managament; Assigned to Arm(s): Conventional Medical Management
B: Arm Label: Burst SCS; Type: ACTIVE_COMPARATOR; Interventions: Device: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10) | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10) | Intervention Type: DEVICE; Name: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10); Assigned to Arm(s): Burst SCS, Sham
C: Arm Label: HF10 therapy plus CMM; Type: ACTIVE_COMPARATOR; Interventions: Device: Senza HF10 Therapy | Arm Label: CMM Alone; Type: OTHER; Interventions: Other: CMM | Intervention Type: DEVICE; Name: Senza HF10 Therapy; Assigned to Arm(s): HF10 therapy plus CMM | Intervention Type: OTHER; Name: CMM; Assigned to Arm(s): CMM Alone
D: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Device: PINS Spinal Cord Stimulator | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Device: PINS Spinal Cord Stimulator | Intervention Type: DEVICE; Name: PINS Spinal Cord Stimulator; Assigned to Arm(s): Control, Experimental

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Anesthesia Management in Endovascular Therapy for Ischemic Stroke: A Multicenter Randomised Study
Brief Summary: Objective of the study: to assess whether pharmacological sedation or general anesthesia for treatment of anterior circulation ischemic stroke with endovascular mechanical thrombectomy is associated with difference in morbidity (neurological outcome and peri-procedural complications).


Options:
A: Arm Label: General anaesthesia; Type: ACTIVE_COMPARATOR; Interventions: Procedure: General anaesthesia | Arm Label: Conscious Sedation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conscious Sedation | Intervention Type: PROCEDURE; Name: General anaesthesia; Assigned to Arm(s): General anaesthesia | Intervention Type: PROCEDURE; Name: Conscious Sedation; Assigned to Arm(s): Conscious Sedation
B: Arm Label: General Anesthesia; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Local Anesthesia; Type: EXPERIMENTAL; Interventions: Procedure: Local anesthesia | Intervention Type: PROCEDURE; Name: Local anesthesia; Assigned to Arm(s): Local Anesthesia
C: Arm Label: intravenous (IV) rt-PA alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV rt-PA alone | Arm Label: Endovascular therapy; Type: EXPERIMENTAL; Interventions: Drug: IV rt-PA alone, Other: endovascular therapy | Intervention Type: DRUG; Name: IV rt-PA alone; Assigned to Arm(s): Endovascular therapy, intravenous (IV) rt-PA alone | Intervention Type: OTHER; Name: endovascular therapy; Assigned to Arm(s): Endovascular therapy
D: Arm Label: general anesthesia; Type: EXPERIMENTAL; Interventions: Drug: Etomidate, Drug: Succinylcholine, Drug: Propofol, Drug: Remifentanil | Arm Label: sedation; Type: EXPERIMENTAL; Interventions: Drug: Remifentanil, Drug: Lidocaine | Intervention Type: DRUG; Name: Etomidate; Assigned to Arm(s): general anesthesia | Intervention Type: DRUG; Name: Succinylcholine; Assigned to Arm(s): general anesthesia | Intervention Type: DRUG; Name: Propofol; Assigned to Arm(s): general anesthesia | Intervention Type: DRUG; Name: Remifentanil; Assigned to Arm(s): general anesthesia, sedation | Intervention Type: DRUG; Name: Lidocaine; Assigned to Arm(s): sedation

Answer: A